31 valent pneumococcal conjugate vaccine

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49NCT07284654PCVXPhase 3Completed2026-09-17Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.